8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)
Published . Updated .
Key takeaways
- 8-K - Eton Pharmaceuticals filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
- Exposed: ETON
- Market reaction: ETON −9.5% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Eton Pharmaceuticals filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- ETON Eton Pharmaceuticals-11.0% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+7.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+5.9% 19d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ETON | -3.80% | -0.59% | base | -2.44% | -2.21% | -2.65% | -9.48% |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.59% | +0.17% |
| XBI | -3.49% | +0.99% | base | -2.51% | -0.66% | +2.01% | -4.85% |
| LLY | -9.71% | -8.92% | base | -0.37% | -0.54% | +0.07% | -3.00% |
| JNJ | -2.53% | -0.72% | base | -0.98% | -2.59% | +1.13% | -0.32% |
| PFE | -2.33% | -3.34% | base | +0.69% | -1.70% | +0.95% | -2.03% |
| MRK | -5.94% | -5.65% | base | -0.74% | -3.26% | +0.55% | -1.48% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-02 AccNo: 0001437749-26-034277 Size: 183 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Eton Pharmaceuticals (ETON) since this story, compared with the market
Since the first closing price after “8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer),” Eton Pharmaceuticals (ETON) is -0.53%.
| Company | When | Move | Status |
|---|---|---|---|
| Eton Pharmaceuticals (ETON) | that day | -2.44% | final price |
| Eton Pharmaceuticals (ETON) | the next day | -2.21% | final price |
| Eton Pharmaceuticals (ETON) | two days later | -2.65% | final price |
| Eton Pharmaceuticals (ETON) | three days later | -9.48% | final price |
| Eton Pharmaceuticals (ETON) | three days earlier | -0.59% | final price |
| Eton Pharmaceuticals (ETON) | five days earlier | -3.80% | final price |
| JNJ | that day | -0.98% | final price |
| JNJ | the next day | -2.59% | final price |
| JNJ | two days later | +1.13% | final price |
| JNJ | three days later | -0.32% | final price |
| JNJ | three days earlier | -0.72% | final price |
| JNJ | five days earlier | -2.53% | final price |
| LLY | that day | -0.37% | final price |
| LLY | the next day | -0.54% | final price |
| LLY | two days later | +0.07% | final price |
| LLY | three days later | -3.00% | final price |
| LLY | three days earlier | -8.92% | final price |
| LLY | five days earlier | -9.71% | final price |
| MRK | that day | -0.74% | final price |
| MRK | the next day | -3.26% | final price |
| MRK | two days later | +0.55% | final price |
| MRK | three days later | -1.48% | final price |
| MRK | three days earlier | -5.65% | final price |
| MRK | five days earlier | -5.94% | final price |
| PFE | that day | +0.69% | final price |
| PFE | the next day | -1.70% | final price |
| PFE | two days later | +0.95% | final price |
| PFE | three days later | -2.03% | final price |
| PFE | three days earlier | -3.34% | final price |
| PFE | five days earlier | -2.33% | final price |
| XBI | that day | -2.51% | final price |
| XBI | the next day | -0.66% | final price |
| XBI | two days later | +2.01% | final price |
| XBI | three days later | -4.85% | final price |
| XBI | three days earlier | +0.99% | final price |
| XBI | five days earlier | -3.49% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Eton Pharmaceuticals (ETON)
Companies mentioned with this story
- ETON Eton Pharmaceuticals
In “8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer),” Eton Pharmaceuticals (ETON) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ETON
How “8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)” reaches Eton Pharmaceuticals (ETON)
The 2 Nov 2026 story “8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)” names Eton Pharmaceuticals (ETON) because of this story.
Eton Pharmaceuticals (ETON) is on the page because SEC 8-K filing -> direct issuer disclosure -> ETON
Dates and price levels for Eton Pharmaceuticals (ETON)
ETON traded between 48.54 and 56.95 across 20 sessions. The latest close on file is 50.78.
How strong the case is around Eton Pharmaceuticals (ETON)
14 out of 100
“8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.